The position of pulmonary carcinoids within the spectrum of neuroendocrine tumors of the lung and other tissues

Genes Chromosomes and Cancer

Volumn 34, Issue 1, 2002, Pages 78-85

  Ullmann, Reinhard ^a   Petzmann, Susanna ^a   Klemen, Huberta ^a   Fraire, Armando E ^b   Hasleton, Phil ^c   Popper, Helmut H ^a,d  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b Institute of Pathology   (United States)

^c WYTHENSHAWE HOSPITAL   (United Kingdom)

^d RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CARCINOID; CHROMOSOME 11Q; CHROMOSOME 3; CHROMOSOME 5Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; HUMAN; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MITOSIS; NECROSIS; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; REPRODUCIBILITY; STATISTICAL ANALYSIS; WORLD HEALTH ORGANIZATION;

ALLELIC IMBALANCE; CARCINOID TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; GENE AMPLIFICATION; HUMANS; LUNG NEOPLASMS;

EID: 0036208414     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10049     Document Type: Article

References (32)

1. Classification of small cell lung cancer and pulmonary carcinoid by gene expression profiles
2. Atypical carcinoid tumors of the lung
3. Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas
4. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung
5. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer
6. Cytogenetic analysis of six bronchial carcinoids
7. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
8. Morphological and immunohistochemical study of typical and atypical carcinoids of the lung with clinico-pathological correlation
9. Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumors
10. Molecular genetic characterization of neuroendocrine lung cancer cell lines
11. Identification of novel regions of altered DNA copy number in small cell lung tumors
12. Chromosomal imbalance maps of malignant solid tumors: A cytogenetic survey of 3185 neoplasms
13. An analysis of 8305 cases of carcinoid tumors
14. Genetic changes in the spectrum of neuroendocrine lung tumors
15. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung
16. Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p
17. Loss of heterozygosity on chromosome arm 11q in lung carcinoids
18. Cytogenetic and CGH studies of four neuroendocrine tumors and tumor-derived cell lines of a patient with multiple endocrine neoplasia type 1
19. Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization
20. Chromosomal alterations in human pancreatic endocrine tumors
21. Comparative genomic hybridization analysis of sporadic neuroendocrine tumors of the digestive system
22. Trisomy 7 in a lung carcinoid tumor: Precocious index of malignant transformation?
23. Reproducibility of neuroendocrine lung tumor classification
24. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid
25. Unbalanced chromosomal aberrations in neuroendocrine lung tumors as detected by comparative genomic hybridization
26. Chromosomal aberrations in a series of large cell neuroendocrine carcinomas: Unexpected divergence from small cell carcinoma of the lung
27. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization
28. Nonrandom structural and numerical chromosome changes in non-small-cell lung cancer
29. Genomic alterations in well-differentiated gastrointestinal and bronchial neuroendocrine tumors (carcinoids): Marked differences indicating diversity in molecular pathogenesis
30. Loss of heterozygosity is related to p53 mutations and smoking in lung cancer